{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:33:53Z","timestamp":1790685233359,"version":"4.1.0"},"reference-count":96,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To describe the adverse events (AEs) of recreational cannabis use in France between 2012 and 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>AEs related to recreational cannabis use, alone or in combination with alcohol and\/or tobacco reported to the French Addictovigilance Network were analysed (excluding cannabidiol and synthetic cannabinoids).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Reporting of AEs tripled between 2012 (<jats:italic>n\u2009=<\/jats:italic>\u00a0179, 6.3%, 95% confidence interval [CI]\u2009=\u20095.4\u20137.2) and 2017 (<jats:italic>n\u2009=<\/jats:italic>\u00a0562, 10.1%, 95% CI\u2009=\u20099.3\u201310.9), reaching 2217 cases. They concerned mainly men (76.4%) and users aged between 18 and 34\u2009years (18\u201325: 30.9%; 26\u201334: 26.3%, range: 12\u201384\u2009years). Cannabis was mainly inhaled (71.6%) and exposure was most often chronic (64.2%). Many types of AEs were reported: psychiatric (51.2%), neurological (15.6%), cardiac (7.8%) and gastrointestinal (7.7%), including unexpected AEs (<jats:italic>n\u2009=<\/jats:italic>\u00a034, 1.1%). The most common effect was dependence, ranging from 10.1% (95% CI\u2009=\u20097.9\u201312.3) to 20.3% (95% CI\u2009=\u200917.3\u201323.2) over the study period. Cannabinoid hyperemesis syndrome (<jats:italic>n\u2009=<\/jats:italic>\u00a087, 2.8%) emerged from 2015. Deaths accounted for 0.2% of all AEs (4 men and 3 women aged on average 35\u2009years). A chronic pattern of cannabis use was reported in 4 of them (intracranial hypertension in the context of lung cancer, suicide, cerebral haematoma, neonatal death with concomitant chronic alcohol use), while in the other cases the toxicological analysis identified cannabis use (ruptured aneurysm and unknown aetiology).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study showed a multitude of AEs related to recreational cannabis use, including unexpected AEs and deaths. It highlights the problem of dependence and the emergence of cannabinoid hyperemesis syndrome.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.14812","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T13:50:44Z","timestamp":1615902644000},"page":"3925-3937","source":"Crossref","is-referenced-by-count":19,"title":["Adverse events of recreational cannabis use reported to the French addictovigilance network (2012\u20132017)"],"prefix":"10.1111","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-1022","authenticated-orcid":false,"given":"Emilie","family":"Bouquet","sequence":"first","affiliation":[{"name":"Addictovigilance Center, Department of Clinical Pharmacology Poitiers University Hospital  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Pain","sequence":"additional","affiliation":[{"name":"Addictovigilance Center, Department of Clinical Pharmacology Poitiers University Hospital  France"},{"name":"INSERM U\u20101084, Experimental and Clinical Neurosciences Laboratory University of Poitiers  Poitiers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Eiden","sequence":"additional","affiliation":[{"name":"Addictovigilance Center Montpellier University Hospital  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3510-2475","authenticated-orcid":false,"given":"Emilie","family":"Jouanjus","sequence":"additional","affiliation":[{"name":"Addictovigilance Center Toulouse University Hospital  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Richard","sequence":"additional","affiliation":[{"name":"French National Agency for Medicines and Health Products Safety (ANSM), Saint\u2010Denis  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fauconneau","sequence":"additional","affiliation":[{"name":"Addictovigilance Center, Department of Clinical Pharmacology Poitiers University Hospital  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Christine","family":"P\u00e9rault\u2010Pochat","sequence":"additional","affiliation":[{"name":"Addictovigilance Center, Department of Clinical Pharmacology Poitiers University Hospital  France"},{"name":"INSERM U\u20101084, Experimental and Clinical Neurosciences Laboratory University of Poitiers  Poitiers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"French Addictovigilance Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"European Monitoring Center for Drugs and Drug Addiction (EMCDDA).European drugs report 2019: Trends and Developments2019."},{"key":"e_1_2_9_3_1","unstructured":"The French Monitoring Centre for Drugs and Drug Addiction (OFDT).Drugs Key data 2019.2019.https:\/\/en.ofdt.fr\/publications\/drugs-key-data\/8th-edition-june-2019\/. Accessed July 30 2019."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20735"},{"key":"e_1_2_9_5_1","first-page":"e000638","article-title":"French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP\u2010A) Working Group on Cannabis Complications","volume":"3","author":"Jouanjus E","year":"2014","journal-title":"Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders J am Heart Assoc"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2018.04.007"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.09.038"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2017.10.010"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2017.01.024"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.08.040"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1052869"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.10.010"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.06.008"},{"key":"e_1_2_9_14_1","first-page":"82","article-title":"Cannabis Use and Dependence among French Schizophrenic Inpatients","volume":"5","author":"Lejoyeux M","year":"2014","journal-title":"Front Psych"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2017.01.007"},{"key":"e_1_2_9_16_1","unstructured":"World Health Organization (WHO).Expert Committee on Drug Dependence Pre\u2010Review. Cannabis plant and cannabis resin. Section 5: Epidemiology.2018.https:\/\/www.who.int\/medicines\/access\/controlled-substances\/ecdd_40_meeting\/en\/. Assessed September 17 2018."},{"key":"e_1_2_9_17_1","unstructured":"The French Monitoring Center for Drugs and Drug Addiction (OFDT) Le Point SINTES N\u00b06.2020.https:\/\/www.ofdt.fr\/BDD\/sintes\/LePointSINTES06.pdf. Assessed November 20 2020."},{"key":"e_1_2_9_18_1","volume-title":"Home Office cannabis potency study 2008","author":"Hardwick S","year":"2008"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015009"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2016.05.001"},{"key":"e_1_2_9_21_1","volume-title":"Relatif aux Substances V\u00e9n\u00e9neuses et \u00e0 l'Organisation de la Pharmacodependance","author":"Minist\u00e8re de l'Emploi et de la Solidarit\u00e9","year":"1999"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.035"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1506"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.149"},{"key":"e_1_2_9_25_1","unstructured":"World Health Organization.The ICD\u201010 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines.1992.https:\/\/www.who.int\/classifications\/icd\/en\/bluebook.pdf. Accessed January 15 2020."},{"key":"e_1_2_9_26_1","unstructured":"MedDRA: Medical Dictionnary for Regulatory Activities.Introductory Guide MedDRA version 21.0.2018.https:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_21_0_english.pdf. Accessed April 30 2020."},{"key":"e_1_2_9_27_1","unstructured":"Institut National de la Statistique et des Etudes Economiques (INSEE).Population totale par sexe et \u00e2ge. INSEE;2019.https:\/\/www.insee.fr\/fr\/statistiques. Accessed April 29 2020."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14747"},{"key":"e_1_2_9_29_1","unstructured":"The French Monitoring Center on Drugs and Drug Addiction (OFDT).Drugs Workbook2019.https:\/\/en.ofdt.fr\/BDD\/publications\/docs\/France2019-03-DrugUseEN.pdf. Assessed April 29 2020."},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.11.009"},{"key":"e_1_2_9_31_1","first-page":"6","article-title":"Alcool, tabac et cannabis an 2014, durant les \u00ab ann\u00e9es coll\u00e8ge\u00bb","volume":"106","author":"Spilka S","year":"2015","journal-title":"Tendances"},{"key":"e_1_2_9_32_1","first-page":"1","article-title":"Usage d'alcool, de tabac et de cannabis chez les adolescents du secondaire en 2018","volume":"132","author":"Spilka S","year":"2019","journal-title":"Tendances"},{"key":"e_1_2_9_33_1","first-page":"6","article-title":"Substance use disorders among French older adults: main trends from the perspective of addictovigilance data. Annual meeting of French Society of Pharmacology and Therapeutics; 12\u201014 June 2019; Lyon (France)","volume":"33","author":"Daveluy A","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1557"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-018-0976-1"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715001178"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419859077"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-psych-113011-143739"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1454406"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743718809339"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4500"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2015.07.008"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.0335"},{"key":"e_1_2_9_44_1","first-page":"e3278","article-title":"Epilepsy and Cannabis: A Literature Review","volume":"10","author":"Zaheer S","year":"2018","journal-title":"Cureus"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0586-5"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2009.03.020"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pec.0000173349.38024.33"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pec.0000204831.96139.52"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.982057"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(74)90361-0"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.01.031"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-017-0663-0"},{"issue":"4","key":"e_1_2_9_53_1","first-page":"1","article-title":"The association between regular cannabis use, with and without tobacco co\u2010use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non\u2010tobacco smokers","volume":"46","author":"Winhusen T","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2018.11.004"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.06.104"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2018.12.002"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.036350"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.10.005"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.09.038"},{"key":"e_1_2_9_60_1","first-page":"e4878","article-title":"A Rare Case of Cannabis\u2010induced Acute Pancreatitis","volume":"11","author":"Ghazaleh S","year":"2019","journal-title":"Cureus"},{"issue":"19","key":"e_1_2_9_61_1","first-page":"8625","article-title":"Cannabis\u2010induced acute pancreatitis: a case report with comprehensive literature review","volume":"23","author":"Pagliari D","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_9_62_1","first-page":"e5754","article-title":"A Case of Cannabis\u2010induced Acute Pancreatitis","volume":"11","author":"John J","year":"2019","journal-title":"Cureus"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.08.040"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2010.01.036"},{"key":"e_1_2_9_65_1","first-page":"026","article-title":"Cannabinoid Induced Pancreatitis: A Case Report and Literature Review","volume":"5","author":"Tripathi N","year":"2017","journal-title":"J Gen Emerg Med"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001143"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000873"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001057"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001256"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000779"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13929"},{"issue":"4","key":"e_1_2_9_72_1","first-page":"462","article-title":"Drowsiness and uncommon fever in a child after cannabis ingestion","volume":"75","author":"Feliu C","year":"2017","journal-title":"Ann Biol Clin"},{"issue":"7","key":"e_1_2_9_73_1","first-page":"491","article-title":"Adverse effects of intravenous cannabis tea","volume":"69","author":"Mims RB","year":"1977","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563659609013773"},{"issue":"4","key":"e_1_2_9_75_1","first-page":"531","article-title":"Lethargic encephalitis. Report of one case","volume":"141","author":"Vadal\u00e1 SF","year":"2013","journal-title":"Rev Med Chil"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000638"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287390600748799"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S188078"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.116335"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20733"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.08.001"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.10.021"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(97)00077-2"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05318.x"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.12.081"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.07.114"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2012.01.013"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2004.10399740"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.09.048"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108028"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.03.007"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.13819"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.15344\/2456-8007\/2019\/132"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110414"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2019.07.024"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.919545"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3280"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14812","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14812","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:33:18Z","timestamp":1693355598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1111\/bcp.14812"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14812","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]}}}